INTERACTION BETWEEN CAFFEINE AND CLOZAPINE - COMMENT

[1] CLINICAL-PHARMACOLOGY OF CAFFEINE [J]. ANNUAL REVIEW OF MEDICINE, 1990, 41 : 277 - 288

[2] CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (05) : 471 - 473

[3] ASSESSMENT OF LIVER METABOLIC FUNCTION - CLINICAL IMPLICATIONS [J]. CLINICAL PHARMACOKINETICS, 1994, 27 (03) : 216 - 248

[4] HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) : 7696 - 7700

[5] CARRILLO JA, 1994, CLIN PHARMACOL THER, V55, P503

[6] GENETICALLY VARIABLE METABOLISM OF ANTIDEPRESSANTS AND NEUROLEPTIC DRUGS IN MAN [J]. PHARMACOGENETICS, 1993, 3 (02): : 61 - 70

[7] DISPOSITION OF CLOZAPINE IN MAN - LACK OF ASSOCIATION WITH DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (01) : 71 - 74

[8] HARING C, 1990, AM J PSYCHIAT, V147, P1471

[9] HIEMKE C, 1994, J CLIN PSYCHOPHARM, V14, P279

[10] FLUVOXAMINE INHIBITION AND CARBAMAZEPINE INDUCTION OF THE METABOLISM OF CLOZAPINE - EVIDENCE FROM A THERAPEUTIC DRUG-MONITORING SERVICE [J]. THERAPEUTIC DRUG MONITORING, 1994, 16 (04) : 368 - 374

[1] CLINICAL-PHARMACOLOGY OF CAFFEINE [J]. ANNUAL REVIEW OF MEDICINE, 1990, 41 : 277 - 288

[2] CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (05) : 471 - 473

[3] ASSESSMENT OF LIVER METABOLIC FUNCTION - CLINICAL IMPLICATIONS [J]. CLINICAL PHARMACOKINETICS, 1994, 27 (03) : 216 - 248

[4] HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) : 7696 - 7700

[5] CARRILLO JA, 1994, CLIN PHARMACOL THER, V55, P503

[6] GENETICALLY VARIABLE METABOLISM OF ANTIDEPRESSANTS AND NEUROLEPTIC DRUGS IN MAN [J]. PHARMACOGENETICS, 1993, 3 (02): : 61 - 70

[7] DISPOSITION OF CLOZAPINE IN MAN - LACK OF ASSOCIATION WITH DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (01) : 71 - 74

[8] HARING C, 1990, AM J PSYCHIAT, V147, P1471

[9] HIEMKE C, 1994, J CLIN PSYCHOPHARM, V14, P279

[10] FLUVOXAMINE INHIBITION AND CARBAMAZEPINE INDUCTION OF THE METABOLISM OF CLOZAPINE - EVIDENCE FROM A THERAPEUTIC DRUG-MONITORING SERVICE [J]. THERAPEUTIC DRUG MONITORING, 1994, 16 (04) : 368 - 374